A variety of dressings are used for burn patients in the clinic, and the difference in efficacy between different dressings is controversial Therefore, we used Bayesian net meta-analysis to evaluate the clinical efficacy of 14 dressings in patients with second-degree burns.
Methods
PubMed, Cochrane Library, Web of Science, Embase, and China Knowledge Network databases were searched to collect randomised controlled trials on different dressings used in the treatment of second-degree burns that met the inclusion criteria from 2010-01 to 2024–12 in each database. Literature was screened by 2 investigators, who independently collected and organised the data for extraction, assessed the quality of the included studies using the Cochrane Risk of Bias tool and Review Manager 5.4, and scored the evidence using GRADEPro. Network meta-analysis (NMA) was performed using R Studio, and SUCRA was used to rank the included dressings for each outcome indicator.
Results
A total of 28 studies containing 2072 patients with second-degree burns and 14 different interventions were included, and the results of the network meta-analysis showed that:1) the top 3 results of the ranked probability of wound healing rate within 2 weeks were: human amniotic membrane (85.3%)>Recombinant human granulocyte macrophage colony stimulating factor(81.7%)>Recombinant Human Erythropoietin(78.1%); ②The top three results in terms of wound healing time were: Recombinant Human Erythropoietin(1.6%)
Conclusion
Based on the SUCRA values and NMA results, we found that Human amniotic membrane can significantly increase the wound healing rate of patients with second-degree burns, Recombinant Human Erythropoietin can significantly shorten the wound healing time, and Heparin has a better effect on reducing the pain of burn patients.However, limited by the quality of the included literature, further high-quality clinical studies are needed to confirm this.
OpriessnigELuzeHSmolleC, et al.Epidemiology of burn injury and the ideal dressing in global burn care - regional differences explored. Burns. 2023;49(1):1–14. doi:10.1016/j.burns.2022.06.018
2.
JordanKCDi GennaroJLvon Saint André-von ArnimAStewartBT. Global trends in pediatric burn injuries and care capacity from the world health organization global burn registry. Front Pediatr. 2022;10:954995. doi: 10.3389/fped.2022.954995
3.
OdondiRNShitsinziREmarahA. Clinical patterns and early outcomes of burn injuries in patients admitted at the Moi teaching and referral hospital in Eldoret, western Kenya. Heliyon. 2020;6(3):e03629. doi: 10.1016/j.heliyon.2020.e03629
4.
YakupuAZhangJDongWSongFDongJLuS. The epidemiological characteristic and trends of burns globally. BMC Public Health. 2022;22(1):1596. doi: 10.1186/s12889-022-13887-2
5.
MorganMDeuisJRFrøsig-JørgensenM, et al.Burn pain: A systematic and critical review of epidemiology, pathophysiology, and treatment. Pain Med. 2018;19(4):708–734. doi: 10.1093/pm/pnx228
6.
AhnHNKangHSParkSJ, et al.Safety and efficacy of basic fibroblast growth factors for deep second-degree burn patients. Burns. 2020;46(8):1857–1866. doi: 10.1016/j.burns.2020.06.019
7.
GreenhalghDG. Management of burns. N Engl J Med. 2019;380(24):2349–2359. doi: 10.1056/NEJMra1807442
8.
BarbachowskaAKorzeniowskiTSurowieckaAStrużynaJ. Alloplastic epidermal skin substitute in the treatment of burns. Life (Basel). 2023;14(1):43. doi: 10.3390/life14010043
9.
WangFZhangXZhangJ, et al.Recent advances in the adjunctive management of diabetic foot ulcer: Focus on noninvasive technologies. Med Res Rev. 2024;44(4):1501–1544. doi: 10.1002/med.22020
10.
Radzikowska-BüchnerEŁopuszyńskaIFliegerWTobiaszMMaciejewskiRFliegerJ. An overview of recent developments in the management of burn injuries. Int J Mol Sci. 2023;24(22):16357. doi: 10.3390/ijms242216357
11.
SurowieckaAStrużynaJWiniarskaAKorzeniowskiT. Hydrogels in burn wound management-A review. Gels. 2022;8(2):122. doi: 10.3390/gels8020122. Erratum in: Gels. 2022 Dec 31;9(1):37. doi: 10.3390/gels9010037.
12.
Markiewicz-GospodarekAKoziołMTobiaszM, et al.Burn wound healing: Clinical complications, medical care, treatment, and dressing types: The current state of knowledge for clinical practice. Int J Environ Res Public Health. 2022;19(3):1338. doi: 10.3390/ijerph19031338
13.
PageMJMoherDBossuytPM, et al.PRISMA 2020 Explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews. Br Med J.2021;372(0):n160. doi: 10.1136/bmj.n160
14.
SaghafiFMohammadiFHoseinzadeF, et al.Potential therapeutic effects of topical recombinant human erythropoietin on burn wound healing: A preliminary randomized double-blind controlled clinical trial. Burns. 2024;50(9):107265. doi: 10.1016/j.burns.2024.09.004
15.
MoghimiMHSalehianMAbdiM, et al.The impact of an open-label design on human amniotic membranes vs. Silver sulfadiazine dressings for second-degree burns: A randomized controlled clinical trial. BMC Surg. 2024;24(1):309. doi: 10.1186/s12893-024-02554-5
16.
HuangZ-zHaoJ-jNingS-c. Effects of nano-silver antibacterial gel and hydrophilic fiber silver dressing on wound repair in patients with deep partial-thickness burns. Physicians Online. 2024;14(10):64–67. DOI:10.3969/j.issn.2095-7165.2024.10.018
17.
AbdullahzadehMShafieeS. To compare the effect of sea buckthorn and silver sulfadiazine dressing on period of wound healing in patients with second-degree burns: A randomized triple-blind clinical trial. Wound Repair Regen. 2021;29(5):732–740. doi: 10.1111/wrr.12916
18.
MoreiraSSCamargoMCCaetanoR, et al.Efficacy and costs of nanocrystalline silver dressings versus 1% silver sulfadiazine dressings to treat burns in adults in the outpatient setting: A randomized clinical trial. Burns. 2022;48(3):568–576. doi: 10.1016/j.burns.2021.05.014
19.
Lima JúniorEMde Moraes FilhoMOCostaBA, et al.A randomized comparison study of lyophilized Nile tilapia skin and silver-impregnated sodium carboxymethylcellulose for the treatment of superficial partial-thickness burns. J Burn Care Res. 2021;42(1):41–48. doi: 10.1093/jbcr/iraa099
20.
Lima JúniorEMde Moraes FilhoMOCostaBA, et al.Nile Tilapia fish skin-based wound dressing improves pain and treatment-related costs of superficial partial-thickness burns: A phase III randomized controlled trial. Plast Reconstr Surg. 2021;147(5):1189–1198. doi: 10.1097/PRS.0000000000007895
21.
Lima JúniorEMDe Moraes FilhoMOCostaBA, et al.Innovative burn treatment using tilapia skin as a Xenograft: A phase II randomized controlled trial. J Burn Care Res. 2020;41(3):585–592. doi: 10.1093/jbcr/irz205
22.
RashaanZMKrijnenPKwaKAvan BaarMEBreederveldRSvan den Akker-van MarleME. Long-term quality of life and cost-effectiveness of treatment of partial thickness burns: A randomized controlled trial comparing enzyme alginogel vs silver sulfadiazine (FLAM study). Wound Repair Regen. 2020;28(3):375–384. doi: 10.1111/wrr.12799
23.
ManzoorSKhanFAMuhammadS, et al.Comparative study of conventional and topical heparin treatment in second degree burn patients for burn analgesia and wound healing. Burns. 2019;45(2):379–386. doi: 10.1016/j.burns.2018.05.010
24.
MaXMDUanP. Effect of external application of platelet-rich plasma on repair of deep partial-thickness burn wounds. J Practical Medical Technology. 2019;26(05):600–602. DOI:10.19522/j.cnki.1671-5098.2019.05.030
25.
KarlssonMElmasryMSteinvallISjöbergFOlofssonPThorfinnJ. Superiority of silver-foam over porcine xenograft dressings for treatment of scalds in children: A prospective randomised controlled trial. Burns. 2019;45(6):1401–1409. doi: 10.1016/j.burns.2019.04.004
26.
FrewQRennekampffHODziewulskiPMoiemenN, BBW-11 Study Group; ZahnTHartmannB. Betulin wound gel accelerated healing of superficial partial thickness burns: Results of a randomized, intra-individually controlled, phase III trial with 12-months follow-up. Burns. 2019;45(4):876–890. doi: 10.1016/j.burns.2018.10.019
27.
AboelnagaAElmasryMAdlyOA, et al.Microbial cellulose dressing compared with silver sulphadiazine for the treatment of partial thickness burns: A prospective, randomised, clinical trial. Burns. 2018;44(8):1982–1988. doi: 10.1016/j.burns.2018.06.007
28.
YeungCYHsiehPSWeiLG, et al.Efficacy of lyophilised platelet-rich plasma powder on healing rate in patients with deep second degree burn injury: A prospective double-blind randomized clinical trial. Ann Plast Surg. 2018;80(2S Suppl 1):S66–S69. doi: 10.1097/SAP.0000000000001328
29.
HuQSuiSWangGD, et al.Effect of rhGM-CSF gel and xenogeneic skin on healing of deep partial-thickness burn wounds. Chin J Med Research. 2017;46(02):149–151.
30.
WattanaploySChinaroonchaiKNamviriyachoteNMuangmanP. Randomized controlled trial of polyhexanide/betaine gel versus silver sulfadiazine for partial-thickness burn treatment. Int J Low Extrem Wounds. 2017;16(1):45–50. doi: 10.1177/1534734617690949
31.
BarretJPPodmelleFLipovýB, et al.BSH-12 and BSG-12 study groups. Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: Results of a randomized phase III clinical trials program. Burns. 2017;43(6):1284–1294. doi: 10.1016/j.burns.2017.03.005
32.
ZhengL. Effect of platelet-rich plasma gel on wound repair in the late stage of deep burn. Clinical Medicine Literature Electronic Journal. 2017;4(82):16096–16097. doi:10.16281/j.carol carroll nki jocml. 2017.82.031
33.
YanDLiuSZhaoX, et al.Recombinant human granulocyte macrophage colony stimulating factor in deep second-degree burn wound healing. Medicine (Baltimore). 2017;96(22):e6881. doi: 10.1097/MD.0000000000006881
34.
XuXMoNChenW-m, et al.Effect of hydrophilic fiber silver dressing and silver sulfadiazine cream in the treatment of deep partial-thickness burns. Drug use Evaluation and Analysis in Chinese Hospitals. 2016;16(04):486–488. DOI:10.14009/j.issn.1672-2124.2016.04.022
35.
YuanLMinghuaCFeifeiD, et al.Study of the use of recombinant human granulocyte-macrophage colony-stimulating factor hydrogel externally to treat residual wounds of extensive deep partial-thickness burn. Burns. 2015;41(5):1086–1091. doi: 10.1016/j.burns.2014.12.004
36.
TangHLvGFuJ, et al.An open, parallel, randomized, comparative, multicenter investigation evaluating the efficacy and tolerability of Mepilex Ag versus silver sulfadiazine in the treatment of deep partial-thickness burn injuries. J Trauma Acute Care Surg. 2015;78(5):1000–1007. doi: 10.1097/TA.0000000000000620
37.
DengHZhaoYXuL, et al.Effect of hydrophilic fiber containing silver dressing on deep partial-thickness burn. Jiangsu Medicine. 2014;40(20):2460–2461. (in Chinese). DOI:10.19460/j.cnki.0253-3685.2014.20.031.
38.
LiuZ-wSuK-xChenJ, et al.Clinical application of external application of platelet-rich plasma in the repair of deep partial-thickness burn wounds. Tianjin Medicine. 2014;42(12):1213–1215. (in Chinese).
39.
GenuinoGABaluyut-AngelesKVEspirituAPLapitanMCBuckleyBS. Topical petrolatum gel alone versus topical silver sulfadiazine with standard gauze dressings for the treatment of superficial partial thickness burns in adults: A randomized controlled trial. Burns. 2014;40(7):1267–1273. doi: 10.1016/j.burns.2014.07.024
40.
YanHChenJPengX. Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel promotes healing of deep partial thickness burn wounds. Burns. 2012;38(6):877–881. doi: 10.1016/j.burns.2012.02.001
41.
MostaqueAKRahmanKB. Comparisons of the effects of biological membrane (amnion) and silver sulfadiazine in the management of burn wounds in children. J Burn Care Res. 2011;32(2):200–209. doi: 10.1097/BCR.0b013e31820aad94
42.
ŻwierełłoWPiorunKSkórka-MajewiczMMaruszewskaAAntoniewskiJGutowskaI. Burns: Classification, pathophysiology, and treatment: A review. Int J Mol Sci. 2023;24(4):3749. doi: 10.3390/ijms24043749
43.
GohMDuMPengWRSawPEChenZ. Advancing burn wound treatment: Exploring hydrogel as a transdermal drug delivery system. Drug Deliv. 2024;31(1):2300945. doi: 10.1080/10717544.2023.2300945
44.
TiwariVK. Burn wound: How it differs from other wounds?Indian J Plast Surg. 2012;45(2):364–373. doi: 10.4103/0970-0358.101319
45.
LloydECRodgersBCMichenerMWilliamsMS. Outpatient burns: Prevention and care. Am Fam Physician. 2012;85(1):25–32.
46.
CookKAMartinez-LozanoESheridanRRodriguezEKNazarianAGrinstaffMW. Hydrogels for the management of second-degree burns: Currently available options and future promise. Burns Trauma. 2022;10:tkac047. doi: 10.1093/burnst/tkac047
47.
RaiMYadavAGadeA. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76–83. doi: 10.1016/j.biotechadv.2008.09.002
48.
LimJZNgNSThomasC. Prevention and treatment of diabetic foot ulcers. J R Soc Med. 2017;110(3):104–109. doi: 10.1177/0141076816688346
49.
SheckterCCVan VlietMMKrishnanNMGarnerWL. Cost-effectiveness comparison between topical silver sulfadiazine and enclosed silver dressing for partial-thickness burn treatment. J Burn Care Res. 2014;35(4):284–290. doi: 10.1097/BCR.0b013e3182a36916
50.
BoldBEUrnukhsaikhanEMishig-OchirT. Biosynthesis of silver nanoparticles with antibacterial, antioxidant, anti-inflammatory properties and their burn wound healing efficacy. Front Chem. 2022;10:972534. doi: 10.3389/fchem.2022.972534
51.
de LimaRSeabraABDuránN. Silver nanoparticles: A brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol. 2012;32(11):867–879. doi: 10.1002/jat.2780
52.
HiroMEPierpontYNKoFWrightTERobsonMCPayneWG. Comparative evaluation of silver-containing antimicrobial dressings on in vitro and in vivo processes of wound healing. Eplasty. 2012;12:e48.
53.
WasiakJClelandHCampbellFSpinksA. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev. 2013;2013(3):CD002106. doi: 10.1002/14651858.CD002106.pub4
54.
KyriopoulosEVan den PlasDPapadopoulosOPapadopoulosSZapandiotiPTsoutsosD. The use of a new wound Alginogel for the treatment of partial-thickness hand burns. Wounds. 2010;22(6):161–164.
55.
HoeksemaHVandekerckhoveDVerbelenJHeynemanAMonstreyS. A comparative study of 1% silver sulphadiazine (Flammazine®) versus an enzyme alginogel (Flaminal®) in the treatment of partial thickness burns. Burns. 2013;39(6):1234–1241. doi: 10.1016/j.burns.2012.12.019
56.
AlvesAPNNLima JúniorEMPiccoloNS, et al.Study of tensiometric properties, microbiological and collagen content in Nile tilapia skin submitted to different sterilization methods. Cell Tissue Bank. 2018;19(3):373–382. doi: 10.1007/s10561-017-9681-y
57.
FiakosGKuangZLoE. Improved skin regeneration with acellular fish skin grafts. Eng Regener. 2020;1(20):95–101. 10.1016/j.engreg.2020.09.002
58.
SethNChopraDLev-TovH. Fish skin grafts with Omega-3 for treatment of chronic wounds: Exploring the role of Omega-3 fatty acids in wound healing and A review of clinical healing outcomes. Surg Technol Int. 2022;40:38–46. doi: 10.52198/22.STI.40.WH1494
59.
FishmanJA. Infectious disease risks in xenotransplantation. Am J Transplant. 2018;18(8):1857–1864. doi: 10.1111/ajt
60.
JenkinsEDYipMMelmanLFrisellaMMMatthewsBD. Informed consent: Cultural and religious issues associated with the use of allogeneic and xenogeneic mesh products. J Am Coll Surg. 2010;210(4):402–410. doi: 10.1016/j.jamcollsurg.2009.12.001
61.
HamedSBennettCLDemiotCUllmannYTeotLDesmoulièreA. Erythropoietin, a novel repurposed drug: An innovative treatment for wound healing in patients with diabetes mellitus. Wound Repair Regen. 2014;22(1):23–33. doi: 10.1111/wrr.12135
62.
HamedSUllmannYEgoziD, et al.Topical erythropoietin treatment accelerates the healing of cutaneous burn wounds in diabetic pigs through an aquaporin-3-dependent mechanism. Diabetes. 2017;66(8):2254–2265. doi: 10.2337/db16-1205
63.
GaleanoMAltavillaDBittoA, et al.Ecombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds. Crit Care Med. 2006;34(4):1139–1146. doi: 10.1097/01.CCM.0000206468
64.
FerriCGiuggioliDSebastianiMColaciM. Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin. Clin Exp Dermatol. 2007;32(3):287–290. doi: 10.1111/j.1365-2230.2007.02363.x
65.
EvertsPOnishiKJayaramPLanaJFMautnerK. Platelet-Rich plasma: New performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794. doi: 10.3390/ijms21207794
66.
MoussaMLajeunesseDHilalG, et al.Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage. Exp Cell Res. 2017;352(1):146–156. doi: 10.1016/j.yexcr.2017.02.012
67.
LiTMaYWangM, et al.Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds. Infect Drug Resist. 2019;12:297–309. doi: 10.2147/IDR.S186651
68.
YeungCYHsiehPSWeiLG, et al.Efficacy of lyophilised platelet-rich plasma powder on healing rate in patients with deep second degree burn injury: A prospective double-blind randomized clinical trial. Ann Plast Surg. 2018;80(2S Suppl 1):S66–S69. doi: 10.1097/SAP.0000000000001328
69.
HuXSunHHanCWangXYuW. Topically applied rhGM-CSF for the wound healing: A systematic review. Burns. 2011;37(5):729–741. doi: 10.1016/j.burns.2010.08.016
70.
ZhaoJChenLShuB, et al.Granulocyte/macrophage colony-stimulating factor influences angiogenesis by regulating the coordinated expression of VEGF and the Ang/Tie system. PLoS One. 2014;9(3):e92691. doi: 10.1371/journal.pone.0092691
71.
DruckerCR. Update on topical antibiotics in dermatology. Dermatol Ther. 2012;25(1):6–11. doi: 10.1111/j.1529-8019.2012.01493.x
72.
ManzoorSKhanFAMuhammadS, et al.Comparative study of conventional and topical heparin treatment in second degree burn patients for burn analgesia and wound healing. Burns. 2019;45(2):379–386. doi: 10.1016/j.burns.2018.05.010
73.
FetterolfDESnyderRJ. Scientific and clinical support for the use of dehydrated amniotic membrane in wound management. Wounds. 2012;24(10):299–307.
74.
Díaz-PradoSMuiños-LópezEHermida-GómezT, et al.Human amniotic membrane as an alternative source of stem cells for regenerative medicine. Differentiation. 2011;81(3):162–171. doi: 10.1016/j.diff.2011.01.005
75.
RoussellePBrayeFDayanG. Re-epithelialization of adult skin wounds: Cellular mechanisms and therapeutic strategies. Adv Drug Deliv Rev. 2019;146:344–365. doi: 10.1016/j.addr.2018.06.019
76.
FénelonMCatrosSMeyerC, et al.Applications of human amniotic membrane for tissue engineering. Membranes (Basel). 2021;11(6):387. doi: 10.3390/membranes11060387
77.
BennettPRBrownRGMacIntyreDA. Vaginal microbiome in preterm rupture of membranes. Obstet Gynecol Clin North Am. 2020;47(4):503–521. doi: 10.1016/j.ogc.2020.08.001
78.
HossainMLRahmanMASiddikaA, et al.Asaduzzaman, burn and wound healing using radiation sterilized human amniotic membrane and centella asiatica derived gel: A review. Regen.Eng. Transl. Med. 2020;6:347–357.
79.
YangCXiongABHeXC, et al.Efficacy and feasibility of amniotic membrane for the treatment of burn wounds: A meta-analysis. J Trauma Acute Care Surg. 2021;90(4):744–755. doi: 10.1097/TA.0000000000003050
